📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model. (2021)

First Author: Fox BC

Attributed to: External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter (EXCITEME) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jimd.12345

PubMed Identifier: 33325042

Publication URI: http://europepmc.org/abstract/MED/33325042

Type: Journal Article/Review

Volume: 44

Parent Publication: Journal of inherited metabolic disease

Issue: 2

ISSN: 0141-8955